- Home
- TMO vs WFC Comparison
TMO vs WFC Comparison
Compare TMO & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TMO | WFC |
|---|---|---|
| Founded | 1956 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Major Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.0B | 224.7B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TMO | WFC |
|---|---|---|
| Price | $590.62 | $88.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 18 |
| Target Price | ★ $636.00 | $96.59 |
| AVG Volume (30 Days) | 2.1M | ★ 9.7M |
| Earning Date | 04-23-2026 | 04-14-2026 |
| Dividend Yield | 0.40% | ★ 2.21% |
| EPS Growth | 7.32 | ★ 16.57 |
| EPS | ★ 9.10 | 3.60 |
| Revenue | $20,918,000,000.00 | ★ $85,063,000,000.00 |
| Revenue This Year | $6.55 | $11.08 |
| Revenue Next Year | $5.11 | $4.76 |
| P/E Ratio | $65.50 | ★ $24.48 |
| Revenue Growth | ★ 14.47 | N/A |
| 52 Week Low | $435.27 | $72.78 |
| 52 Week High | $643.99 | $97.76 |
Technical Indicators
Market Signals| Indicator | TMO | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 65.23 | 57.10 |
| Support Level | $557.05 | $83.77 |
| Resistance Level | $596.47 | $89.98 |
| Average True Range (ATR) | 13.61 | 1.70 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 68.52 | 76.01 |
Price Performance
Historical ComparisonAbout TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
About WFC Wells Fargo & Company
Wells Fargo is a premier, North American-focused banking titan that commands a $2.2 trillion balance sheet and the third-highest deposit market share in the United States. The bank uses a dense, expansive network of 4,093 branches to champion retail consumers and the middle market, where the firm has built a particularly strong reputation. Following the removal of its federal asset cap in 2025, the firm is set to deploy its legacy excess liquidity to expand each of its four segments: consumer & business lending, commercial banking, corporate & investment banking, and wealth & investment management.